Home › Funds › First Turn Management, LLC › ERAS
First Turn Management, LLC position in ERAS
ERASCA INC · Health Care
First Turn Management, LLC reported holding 913,452 shares of ERAS (ERASCA INC) in its Q3 2026 13F filing — a position valued at US$13.4M, representing 1.78% of its reported portfolio and ranking #28 among its reported holdings. First Turn Management, LLC has disclosed ERAS holdings in 3 of the last 3 reported quarters, going back to Q1 2026.
Last updated: 2026-11-16 · Source: SEC EDGAR Form 13F-HR
How First Turn Management, LLC's ERAS position evolved
First Turn Management, LLC first disclosed a stake in ERAS in Q1 2026 at 867,639 shares (US$14.0M). The position peaked in Q2 2026 at 1,221,721 shares, worth US$22.4M. Across 3 filings, First Turn Management, LLC increased the stake 1 time(s), trimmed it 1 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 913,452 shares valued at US$13.4M — a reduction of -308,269 shares quarter over quarter.. Notable position changes include a 41% increase in Q2 2026 (shares fell 20% over the following quarter), a 25% trim in Q3 2026 (shares rose 7% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q1 2026 | 867.64K | $14.04M | New |
| Q2 2026 | 1.22M | $22.38M | Add |
| Q3 2026 | 913.45K | $13.39M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About ERAS and 13F data
ERAS (ERASCA INC) is a Health Care company. 73 other funds we track also report a position in ERAS — the largest reported positions include Frazier Life Sciences Management, L.P. (US$457.5M), RTW INVESTMENTS, LP (US$329.1M), Venrock Adviser, LLC (US$327.8M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding ERAS
- Frazier Life Sciences Management, L.P. 24.98M sh · $457.55M · Q2 2026
- RTW INVESTMENTS, LP 22.45M sh · $329.07M · Q3 2026
- Venrock Adviser, LLC 17.89M sh · $327.78M · Q2 2026
- Siren, L.L.C. 13.20M sh · $193.48M · Q3 2026
- ARCH Venture Management, LLC 7.09M sh · $129.92M · Q2 2026
- Paradigm Biocapital Advisors LP 8.00M sh · $117.25M · Q3 2026
- Cormorant Asset Management, LP 6.00M sh · $109.92M · Q2 2026
- Affinity Asset Advisors, LLC 5.59M sh · $81.96M · Q3 2026
- Vivo Capital, LLC 4.02M sh · $58.94M · Q3 2026
- a16z Capital Management, L.L.C. 2.86M sh · $52.44M · Q2 2026
- Soleus Capital Management, L.P. 2.70M sh · $49.46M · Q2 2026
- EcoR1 Capital, LLC 2.95M sh · $43.25M · Q3 2026
More on First Turn Management, LLC
FAQ
How long has First Turn Management, LLC held ERAS?
First Turn Management, LLC has disclosed ERAS holdings in 3 of the last 3 reported quarters, going back to Q1 2026.
What is First Turn Management, LLC's current position in ERAS?
As of Q3 2026, First Turn Management, LLC holds 913.45K shares of ERAS (ERASCA INC), valued at $13.39M, representing 1.78% of its reported portfolio and ranking #28.
Has First Turn Management, LLC been buying or selling ERAS?
In the latest 13F filing (Q3 2026), First Turn Management, LLC reduced its position in ERAS. The position peaked in Q2 2026 at 1.22M shares.
Which other funds hold ERAS?
Other major institutional holders of ERAS include Frazier Life Sciences Management, L.P., RTW INVESTMENTS, LP, Venrock Adviser, LLC, among 73 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.